Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
摘要
<p>The invention provides novel compounds that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases.</p>